Glynss Banzuelo

Biotechnology

Patent Snapshot: Averna’s tech on safer, more precise gene insertion

Averna Therapeutics is a Boston‑based biotechnology company developing genomic medicines that insert therapeutic genetic material into defined locations within the human genome. Targeted insertion at…
January 29, 2026

Sign up to get access​

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Please provide accurate and verifiable contact information to ensure proper use of our materials and prevent misuse. Thank you for your understanding!
Name*
Important: To prevent misuse of our materials, all report download requests undergo a verification and approval process. Providing your email does not guarantee immediate access.
Consent
This field is hidden when viewing the form
This field is hidden when viewing the form

Sign up to get access

Please provide accurate and verifiable contact information to ensure proper use of our materials and prevent misuse. Thank you for your understanding!

Important: To prevent misuse of our materials, all report download requests undergo a verification and approval process. Providing your email does not guarantee immediate access.

Subscribe to our newsletter

  • This field is for validation purposes and should be left unchanged.
  • Questions? Check our privacy policy.